Cristian Diego Gutierrez Reyes

Dr. Cristian Diego Gutierrez Reyes

Texas Tech University, Lubbock, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CRCristian Diego Gutierrez Reyes
Cristian Diego Gutierrez Reyes
GAGerardo Alejo-Jacuinde
Gerardo Alejo-Jacuinde
BSBENJAMIN PEREZ SANCHEZ
BENJAMIN PEREZ SANCHEZ
JCJesús Chávez-Reyes
Jesús Chávez-Reyes
SOShreifdeen Onigbinde
Shreifdeen Onigbinde
Yehia MechrefYehia Mechref
Yehia Mechref
Traditional methodologies often fall short in addressing the complexity of biological systems. In this regard, system biology omics have brought invaluable tools for conducting comprehensive analysis. Current sequencing capabilities have revolutionized genetics and genomics studies, as well as the characterization of transcriptional profiling and dynamics of several species and sample types. Biological systems experience complex biochemical processes involving thousands of molecules. These processes occur at different levels that can be studied using mass spectrometry-based (MS-based) analysis, enabling high-throughput proteomics, glycoproteomics, glycomics, metabolomics, and lipidomics analysis. Here, we present the most up-to-date techniques utilized in the completion of omics analysis. Additionally, we include some interesting examples of the applicability of multi omics to a variety of biological systems.

6 October 2021 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
CRCristian Diego Gutierrez Reyes
Cristian Diego Gutierrez Reyes
PJPeilin Jiang
Peilin Jiang
MAMojgan Atashi
Mojgan Atashi
ABAndrew I. Bennett
Andrew I. Bennett
AYAiying Yu
Aiying Yu
Yehia MechrefYehia Mechref
Yehia Mechref

23 August 2021 in Metabolites
Verified
Journal Article
Open access
PDF file
CRCristian Diego Gutierrez Reyes
Cristian Diego Gutierrez Reyes
YHYifan Huang
Yifan Huang
MAMojgan Atashi
Mojgan Atashi
JZJie Zhang
Jie Zhang
JZJianhui Zhu
Jianhui Zhu
Yehia MechrefYehia Mechref
Yehia Mechref
Currently, surveillance strategies have inadequate performance for cirrhosis and early detection of hepatocellular carcinoma (HCC). The glycosylation of serum haptoglobin has shown to have significant differences between cirrhosis and HCC, thus can be used for diagnosis. We performed a comprehensive liquid chromatography—parallel reaction monitoring—mass spectrometry (LC-PRM-MS) approach, where a targeted parallel reaction monitoring (PRM) strategy was coupled to a powerful LC system, to study the site-specific isomerism of haptoglobin (Hp) extracted from cirrhosis and HCC patients. We found that our strategy was able to identify a large number of isomeric N-glycopeptides, mainly located in the Hp glycosylation site Asn207. Four N-glycopeptides were found to have significant changes in abundance between cirrhosis and HCC samples (p < 0.05). Strategic combinations of the significant N-glycopeptides, either with alpha-fetoprotein (AFP) or themselves, better estimate the areas under the curve (AUC) of their respective receiver operating characteristic (ROC) curves with respect to AFP. The combination of AFP with the isomeric sialylated fucosylated N-glycopeptides Asn207 + 5-6-1-2 and Asn207 + 5-6-1-3, resulted with an AUC value of 0.98, while the AUC value for AFP alone was 0.85. When comparing cirrhosis vs. early HCC, the isomeric N-glycopeptide Asn207 + 5-6-0-1 better estimated AUC with respect to AFP (AUCAFP = 0.81, and AUCAsn207 + 5-6-0-1 = 0.88, respectively).

8 November 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
CRCristian Diego Gutierrez Reyes
Cristian Diego Gutierrez Reyes
MHMd Abdul Hakim
Md Abdul Hakim
MAMojgan Atashi
Mojgan Atashi
MGMona Goli
Mona Goli
SGSakshi Gautam
Sakshi Gautam
Yehia MechrefYehia Mechref
Yehia Mechref
Mild cognitive impairment (MCI) is an early stage of memory loss that affects cognitive abilities, such as language or virtual/spatial comprehension. This cognitive decline is mostly observed with the aging of individuals. Recently, MCI has been considered as a prodromal phase of Alzheimer’s disease (AD), with a 10–15% conversion rate. However, the existing diagnostic methods fail to provide precise and well-timed diagnoses, and the pathophysiology of MCI is not fully understood. Alterations of serum N-glycan expression could represent essential contributors to the overall pathophysiology of neurodegenerative diseases and be used as a potential marker to assess MCI diagnosis using non-invasive procedures. Herein, we undertook an LC-MS/MS glycomics approach to determine and characterize potential N-glycan markers in depleted blood serum samples from MCI patients. For the first time, we profiled the isomeric glycome of the low abundant serum glycoproteins extracted from serum samples of control and MCI patients using an LC-MS/MS analytical strategy. Additionally, the MRM validation of the identified data showed five isomeric N-glycans with the ability to discriminate between healthy and MCI patients: the sialylated N-glycans GlcNAc5,Hex6,Neu5Ac3 and GlcNAc6,Hex7,Neu5Ac4 with single AUCs of 0.92 and 0.87, respectively, and a combined AUC of 0.96; and the sialylated-fucosylated N-glycans GlcNAc4,Hex5,Fuc, Neu5Ac, GlcNAc5,Hex6,Fuc, Neu5Ac2, and GlcNAc6,Hex7,Fuc, Neu5Ac3 with single AUCs of 0.94, 0.67, and 0.88, respectively, and a combined AUC of 0.98. According to the ingenuity pathway analysis (IPA) and in line with recent publications, the identified N-glycans may play an important role in neuroinflammation. It is a process that plays a fundamental role in neuroinflammation, an important process in the progression of neurodegenerative diseases.

1 January 2020 in Journal of Analytical and Applied Pyrolysis
Verified
Journal Article
Closed access
Ananda Sarath AmarasekaraAnanda Sarath Amarasekara
Ananda Sarath Amarasekara
CRCristian Diego Gutierrez Reyes
Cristian Diego Gutierrez Reyes

20 September 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
CRCristian Diego Gutierrez Reyes
Cristian Diego Gutierrez Reyes
SOShreifdeen Onigbinde
Shreifdeen Onigbinde
ASAkeem Sanni
Akeem Sanni
ABAndrew I. Bennett
Andrew I. Bennett
PJPeilin Jiang
Peilin Jiang
Yehia MechrefYehia Mechref
Yehia Mechref
The SARS-CoV-2 virus rapidly spread worldwide, threatening public health. Since it emerged, the scientific community has been engaged in the development of effective therapeutics and vaccines. The subunit S1 in the spike protein of SARS-CoV-2 mediates the viral entry into the host and is therefore one of the major research targets. The S1 protein is extensively glycosylated, and there is compelling evidence that glycans protect the virus’ active site from the human defense system. Therefore, investigation of the S1 protein glycome alterations in the different virus variants will provide a view of the glycan evolution and its relationship with the virus pathogenesis. In this study, we explored the N-glycosylation expression of the S1 protein for eleven SARS-CoV-2 variants: five variants of concern (VOC), including alpha, beta, gamma, delta, and omicron, and six variants of interest (VOI), including epsilon, eta, iota, lambda, kappa, and mu. The results showed significant differences in the N-glycome abundance of all variants. The N-glycome of the VOC showed a large increase in the abundance of sialofucosylated glycans, with the greatest abundance in the omicron variant. In contrast, the results showed a large abundance of fucosylated glycans for most of the VOI. Two glycan compositions, GlcNAc4,Hex5,Fuc,NeuAc (4-5-1-1) and GlcNAc6,Hex8,Fuc,NeuAc (6-8-1-1), were the most abundant structures across all variants. We believe that our data will contribute to understanding the S1 protein’s structural differences between SARS-CoV-2 mutations.